SARS-CoV-2 qRT-PCR Dx Kit
The Agilent SARS-CoV-2 qRT-PCR Dx kit is a real-time reverse transcriptase PCR (qRT-PCR) in vitro diagnostic test for qualitative detection of SARS-CoV-2 RNA. Viral RNA is isolated and purified from nasopharyngeal, nasal and oropharyngeal human swab specimens1 obtained from individuals suspected of having COVID-19 by their healthcare provider.
Positive results from these upper respiratory specimens are indicative of the presence of SARS-CoV-2 viral RNA. Clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status.
The Agilent SARS-CoV-2 qRT-PCR Dx kit has been designed for flexibility across the entire workflow. The open system has been validated with two commercially available RNA extraction products and three real-time PCR systems, including the AriaDx Real-Time PCR System.4
The Agilent SARS-CoV-2 qRT-PCR Dx kit is CE-IVD marked in accordance with the European Union In Vitro Diagnostic Directive 98/79/EC.
For In Vitro Diagnostic Use.